top of page
Pipeline
Our products pipeline shows the current progress in our clinical programs. We are advancing personalized immunotherapies starting with our lead product of individualized neoantigen cancer vaccine against multiple cancer indications.
Explore our pipeline
Candidate
Preclinical
Phase I/II
Phase III
SQK01 Neoantigen cancer vaccine (solid tumors)
Lung cancer vaccine (public vaccine design)
bottom of page